Bio-Rad Laboratories, Inc.
BIO
$245.01
-$6.14-2.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -209.59% | 130.16% | -664.05% | 9.77% | 229.14% |
| Total Depreciation and Amortization | 0.77% | 6.87% | -1.89% | -0.27% | -0.27% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 235.72% | -125.78% | 817.19% | -36.10% | -586.94% |
| Change in Net Operating Assets | -197.87% | 132.48% | -1,358.33% | 758.54% | -228.00% |
| Cash from Operations | -24.07% | 67.51% | 39.91% | -13.84% | -17.11% |
| Capital Expenditure | -6.67% | 4.85% | -5.24% | 4.94% | 4.10% |
| Sale of Property, Plant, and Equipment | -185.96% | -13.64% | 153.85% | -72.92% | 47.69% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 180.31% | -237.00% | 483.55% | -102.63% | 224.17% |
| Cash from Investing | 45.10% | -79.89% | 28.23% | -159.69% | 859.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 66.67% | -4.24% | 0.00% | 21.85% | -27.97% |
| Issuance of Common Stock | -23.36% | 8.95% | -14.93% | 27.08% | -6.78% |
| Repurchase of Common Stock | 99.87% | 0.18% | -2,029.96% | 97.68% | -557.80% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -- | -- |
| Cash from Financing | 72.65% | 0.62% | -460,038.10% | 100.01% | -654.09% |
| Foreign Exchange rate Adjustments | 236.01% | -296.16% | 43.86% | 141.03% | -204.34% |
| Miscellaneous Cash Flow Adjustments | -200.00% | -- | -- | -- | 200.00% |
| Net Change in Cash | 1,634.43% | 117.18% | -188.61% | 154.54% | -179.42% |
